This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
2. : J apanese gas t r i c cancer treatment guidelines 2010 (ver.3). Gastric Cancer: online 14 May 2011.
3. Saka M, Morita S, Fukagawa T: Present and Future Status of Gastric Cancer Surgery. Jpn J Clin Oncol 2011; 41(3): 307-13.
4. Wu CW, Hsiung CA, Lo SS: Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 2006; 7: 309-15.
5. Songun I, Putter H, Kranenbarg EM: Surgical
2015 59 7 46
treatment of gastric cancer: 15-year follow-up results of the randomized nationwide Dutch D1D2 trial. Lancet Oncol 2010; 11: 439-49.
6. Degiuli M, Sasako M, Ponti A: Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg 2010; 97: 643-9.
7. S a s a k o M , S a n o T, Ya m a m o t o S : D 2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008; 359: 453-62
8. Tsujitani S, Oka S, Saito H: Less invasive surgery for early gastric cancer based on the low probability of lymph node metastasis. Surgery 1999; 125: 148-54.
9. Kitano S, Iso Y, Moriyama M: Laparoscopic-assisted Billroth I gastrectomy. Surg Laparosc Endosc 1994; 4: 146-8
10. Katai H, Sasako M, Fukuda H, et al: Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG 0703). Gastric Cancer 2010; 13: 238-44.
11. Nakamura K, Katai H, Mizusawa J, et al: th Nodal Dissection for Clinical Stage IA/IB Gastric Cancer (JCOG0912). Jpn J Clin Oncol 2013; 43: 324-7.
12. K i m H H , H y u n g W J , C h o G S , e t a l : Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report--a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann Surg 2010; 251: 417-20.
13. Sakuramoto S, Sasako M, Yamaguchi T, et al: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007; 357: 1810–20.
14. Sasako M, Sakuramoto S, Katai H, et al: Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer. J Clin Oncol 2011; 29: 4387–93
15. Bang YJ, Kim YW, Yang HK, et al: Adjuvant capecitabine and oxaliplatin for gastric cancer: results of the phase III CLASSIC trial. 2011 ASCO Annual Meeting. J Clin Oncol 2011; 29: LBA4002.
16. Cunningham D, Allum WH, Stenning SP, et al: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20.
17. Kochi M, Fujii M, Kanamori N, et al: Phase II Study of Neoadjuvant Chemotherapy With S-1 and CDDP in Patients With Lymph Node Metastatic Stage II or III Gastric Cancer. Am
2015 59 7 47
J Clin Oncol 2014 Mar 21. [Epub ahead of print]
18. Bang YJ, Cutsem EV, Andrea F, et al: for t rea tment of HER2-pos i t ive advanced gastr ic or gastro-oesophageal junct ion cancer (ToGA): a phase 3, open-label , randomised controlled trial. The Lancet 2010; 376(9742): 687-97.
19. Hiroaki N, Akihiko K, Shigetoyo S, et al: Efficacy of Immunochemotherapy as Adjuvant Treatment after Curative Resection of Gastric Cancer. Lancet 1994; 343: 1122-6.